Mint Tower Capital Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Mint Tower Capital Management’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40,000	Closed	-$1K	–	204
2025 Q1	$1K	Hold	40,000	–	–	﹤0.01%	146
2024 Q4	$4K	Hold	40,000	–	–	﹤0.01%	128
2024 Q3	$3K	Hold	40,000	–	–	﹤0.01%	129
2024 Q2	$3K	Hold	40,000	–	–	﹤0.01%	119
2024 Q1	$6K	Hold	40,000	–	–	﹤0.01%	158
2023 Q4	$3K	Hold	40,000	–	–	﹤0.01%	156
2023 Q3	$16K	Hold	40,000	–	–	﹤0.01%	212
2023 Q2	$8K	Hold	40,000	–	–	﹤0.01%	207
2023 Q1	$6K	Hold	40,000	–	–	﹤0.01%	234
2022 Q4	$3K	Buy	+40,000	New	+$3.36K	﹤0.01%	341

Mint Tower Capital Management's NKGNW Position: Q2 2025 in Review

Mint Tower Capital Management sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q2 2025, closing a stake of 40,000 shares — an estimated $1K sold.

Mint Tower Capital Management first reported a position in NKGNW in Q4 2022 and held it in 10 quarters. The position peaked at $16K in Q3 2023. 0 funds tracked by Wall St. Rank hold NKGNW as of Q2 2025.

Mint Tower Capital Management reported no remaining NKGen Biotech, Inc. Warrants position as of Q2 2025 after selling out during the quarter.
Mint Tower Capital Management sold 40,000 NKGen Biotech, Inc. Warrants shares in Q2 2025, an estimated $1K.
Mint Tower Capital Management first reported a position in NKGen Biotech, Inc. Warrants in Q4 2022 and held it in 10 quarters.
Mint Tower Capital Management's NKGen Biotech, Inc. Warrants position peaked at $16K in Q3 2023.
0 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q2 2025.

Based on Mint Tower Capital Management's 13F filing for Q2 2025, filed 11 Aug 2025.